First Wave BioPharma Inc. sell nvestor
Start price
11.01.20
/
50%
€2,895.1
Target price
25.01.20
€0.000
Performance (%)
-32.25%
End price
25.01.20
€1,961.5
Summary
This prediction ended on 25.01.20 with a price of €1,961.5. nvestor correctly predicted massive losses of -32.25% for First Wave BioPharma Inc.. nvestor has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
First Wave BioPharma Inc. | - | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
According to nvestor what are the pros and cons of First Wave BioPharma Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
Higher risks for its business
Below average Marketposition
Little known brand
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
negative Cash Flow expected
Little Investments for future growth
Risky balance sheet
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
high free float
Significant cyclical dependencies
Outdated or very high risk business model
Comments by nvestor for this prediction
In the thread First Wave BioPharma Inc. diskutieren
Sell mit Kursziel 0,0
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by nvestor for First Wave BioPharma Inc.
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€8.22
15.10.22
15.10.22
€0.000
15.10.23
15.10.23
2.13%
29.10.22
29.10.22
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€675.52
18.09.21
18.09.21
€209.79
18.09.22
18.09.22
-25.47%
02.10.21
02.10.21
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€3,293.7
23.01.21
23.01.21
€0.000
23.01.22
23.01.22
-55.41%
26.06.21
26.06.21
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important